How should I use Vabysmo(Faricimab-svoa)?

The recommended dose is 6 mg via intravitreal injection, with frequency varying by condition and treatment response.

Administration Guidelines

For nAMD, administer 6 mg every 4 weeks for the first 4 doses, then adjust based on evaluations. For DME, options include every 4 weeks for at least 4 doses or every 4 weeks for 6 doses followed by every 8 weeks. For RVO, give 6 mg every 4 weeks for 6 months. Dosing intervals may be modified based on optical coherence tomography and visual acuity assessments. All injections must be performed by a qualified physician under aseptic conditions.

Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular edema, and macular edema secondary to retinal vein occlusion.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved